Akums Drugs and Pharmaceutical

BSE
AKUMS
Stock
Yield per half year: -7.49%
Dividend yield: 0%

Reporting Akums Drugs and Pharmaceutical

Capitalization

IFRS
Reporting Annual
5 year average CAGR 5


Share

IFRS
Reporting Annual Quarterly
2024 2025 LTM 5 year average CAGR 5
Цена акции ао 638.1 582.05 582.05 610.08 -4.49


Efficiency

IFRS
Reporting Annual
2024 2025 LTM Industry average 5 year average CAGR 5
ROS, % 0 0 0 11.95
ROCE, % 0 0 5.21
Ebit margin, % 0 0
Рентаб EBITDA, % 0 0 22.82
Operation Margin, % 0 0 0 16.44


Coefficients

IFRS
Reporting Annual Quarterly
2024 2025 LTM Industry average 5 year average CAGR 5
P/FCF
0 0 0 221.22
E/P
0 0 0 0.05
EV/EBIT
0 0 0
EV/S
0 0 0 5.22
EV/FCF
0 0 0 214.21
Debt/EBITDA
0 0 0 1.06
Netdebt/Ebitda
0 0 0 0.86
Debt/Ratio
0 0 0 0.13
Debt/Equity
0 0 0 0.95
Debt/Net Income
0 0 0 4.34
PEG
0 0
Бета
-0.1644 1.46 1.46 0.66 0.6478 -398.01
Индекс Альтмана
0 0 0 7.89


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 14.96


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe